Ananthapadmanabhan Shravankrishna, Williams Zoe, Wang Henry, Combes Alexander, Wong Veronica, Thangasamy Isaac
Nepean Urology Research Group, Nepean Hospital, Kingswood, New South Wales, 2747, Australia.
Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood, New South Wales, 2747, Australia.
Urol Case Rep. 2024 Jul 3;55:102787. doi: 10.1016/j.eucr.2024.102787. eCollection 2024 Jul.
When localised prostate cancer recurs after treatment, it occurs predictably in sites such as the prostatic bed, pelvic lymph nodes, spine, lung, and liver. Urethral metastasis of prostate cancer is exceedingly rare. We report a case of urethral recurrence of prostate cancer presenting as new lower urinary tract symptoms in an 82-year-old male 10 years after robotic radical prostatectomy with a very low PSA level of 0.05μg/L. This rare case highlights the need to maintain a degree of suspicion for prostate cancer recurrence in patients with a late onset of or changing lower urinary tract symptoms after radical prostatectomy.
当局限性前列腺癌治疗后复发时，其复发部位可预测，如前列腺床、盆腔淋巴结、脊柱、肺和肝脏。前列腺癌尿道转移极为罕见。我们报告一例前列腺癌尿道复发病例，该病例为一名82岁男性，在机器人辅助根治性前列腺切除术后10年出现新的下尿路症状，其前列腺特异性抗原（PSA）水平极低，仅为0.05μg/L。这一罕见病例凸显了对于根治性前列腺切除术后出现较晚或变化的下尿路症状的患者，需要对前列腺癌复发保持一定程度的怀疑。
